Analysis of Complex Transactions
In the context of the impending bankruptcy of a major corporation, Cornerstone Research worked with a finance expert to analyze a complex transaction that was alleged to constitute a fraudulent…
Bank Holding Company Bankruptcy
In a claim brought by the trustee of a bankrupt bank holding company, defense counsel retained Cornerstone Research.
Disclosure
Cornerstone Research was retained by a law firm representing a computer maker in a decade long securities class-action suit.
Failed Hedge Funds and Insurers
In cases arising from the failures of hedge funds and insurers, Cornerstone Research has worked with Professor René Stulz of The Ohio State University to assess investment strategies and to…
High Yield Debt Pricing
Cornerstone Research supported two experts who addressed allegations regarding an investment bank’s role in the failure of a life insurance company.
Valuation of Emerging Market Company Bonds
Cornerstone Research analyzed the relative value of several classes of high yield bonds issued by an emerging market company that subsequently failed.
Acquisition of Private Biotechnology Company
In a securities case filed in the state of California, shareholders of a privately held biotechnology company brought suit against a pharmaceutical company that had acquired the biotechnology company in…
Biotechnology Shareholder Breach of Fiduciary Duty
Minority shareholders in a financially troubled biotechnology company alleged that the majority shareholder drove the company’s choices of funding sources and that the interests of minority shareholders were not properly…
Failure to Disclose Clinical Trial Results
Counsel for a pharmaceutical company retained Cornerstone Research to assess damages in a securities class action alleging the company misled investors about a drug’s approval probability.
Misleading Disclosure of Clinical Trial Results
Plaintiffs filed a securities class action against a major pharmaceutical company alleging that the company made false and misleading statements regarding the results of a drug’s safety study.
How can we help you?
If you are looking for additional case experience examples, contact us.